Showing results (341-350 of 11,530) with videos related to

Sort By:
Pageof 1,153
British Journal of Clinical Pharmacology|February 13, 2001
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapyA D Huitema, R A Mathôt, M M Tibben, et al.
British Journal of Clinical Pharmacology|February 13, 2001
Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidolJ G Shin, K Kane, D A Flockhart
British Journal of Clinical Pharmacology|February 13, 2001
Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoningL E Schmidt, K Dalhoff
British Journal of Clinical Pharmacology|February 13, 2001
Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulationsP T Daley-Yates, R C Baker
British Journal of Clinical Pharmacology|September 1, 1987
Circulatory and respiratory effects of infused adenosine in conscious manR W Fuller, D L Maxwell, T B Conradson, et al.
British Journal of Clinical Pharmacology|January 14, 2023
Impact of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantationToshinori Hirai, Yoshihiko Morikawa, Ritsuki Onishi, et al.
British Journal of Clinical Pharmacology|December 1, 1978
The electrocardiogram in the assessment of the effect of drugs on cardiac arrhythmiasD S Reid
British Journal of Clinical Pharmacology|June 1, 1986
Knowledge of and attitudes to medicines in the Southampton communityS Ridout, W E Waters, C F George
British Journal of Clinical Pharmacology|March 1, 1985
Comparative clinical efficacy of bepridil, propranolol and placebo in patients with chronic stable anginaA P Rae, J M Beattie, T D Lawrie, et al.
Pageof 1,153